Flash Sale 70% Off
Give customers details about the banner image(s) or content on the template.
THE FELINE GUT HEALTH SERIES — This is the fourth article in our September series on the feline gut. We started with what the cat gut microbiome actually is and what disrupts it, looked at the hidden toll of antibiotics, and reviewed what the evidence really shows about diarrhea and probiotics. Here we look at the connection between the gut and the immune system — including where the popular version of that story outruns the research.
Your cat's intestinal lining is a single layer of cells separating the inside of the body from an enormous, constantly changing population of bacteria, food particles, and anything else that arrives by mouth. It has to let nutrients through while keeping most of the rest out — and it has to decide, thousands of times a day, what is harmless and what is not.
That decision-making doesn't happen in the abstract. It happens in tissue. Gut-associated lymphoid tissue — tonsils, Peyer's patches, and diffuse lymphoid tissue distributed along the GI tract — sits directly beneath and within the gut lining. Peyer's patches are the induction sites: specialized M cells sample material from the gut lumen, dendritic cells present it, T cells respond, and B cells class-switch to produce immunoglobulin A, the antibody that coats mucosal surfaces.
This is why gut health and immune function are discussed together. It isn't a marketing metaphor. It's anatomy.
Where we part company with the usual claim. The line you'll see repeated everywhere — including, we'll note, on plenty of pet supplement labels — is that "70% of the immune system is in the gut." That figure traces back to human and general mammalian mucosal immunology. We have not been able to find a feline-specific study that establishes it in cats. So we don't say it. The gut being a major immune interface in cats is well supported. A specific percentage in cats is not.
The bacteria living in the gut aren't passive tenants. They ferment fiber into short-chain fatty acids, transform bile acids, and metabolize tryptophan — and those metabolites are among the main signals that shape inflammation and cell turnover in the intestinal lining. The microbes talk to the immune system chemically, and the immune system adjusts.
In cats, this relationship shows up most clearly when it goes wrong. Research using a feline dysbiosis index found that roughly three-quarters of cats with chronic enteropathy have an altered fecal microbiota, with patterns resembling those seen in human inflammatory bowel disease. Studies of feline chronic enteropathy consistently report reduced bacterial diversity, lower abundance of beneficial taxa such as Bifidobacterium and members of the Ruminococcaceae, and higher abundance of Enterobacteriaceae. Altered microbial tryptophan metabolism has been documented in cats with chronic inflammatory enteropathy and low-grade intestinal T-cell lymphoma.
Here is the honest framing: these are associations observed in cats with disease. They establish that gut microbial composition and intestinal immune status travel together in cats. They do not establish that changing the microbiome of a healthy cat changes that cat's immune outcomes. Those are different questions, and only the first one is settled. We wrote more about what disrupts the feline microbiome in the first article in this series.
Beta-glucans are polysaccharides from yeast and fungal cell walls. Their interaction with the mammalian immune system is one of the better-characterized stories in nutritional immunology: they are recognized by pattern-recognition receptors on innate immune cells, principally Dectin-1 and complement receptor 3, which is how a non-infectious dietary compound can register as a signal at all.
The language you'll usually see next is that beta-glucans "prime the immune system without triggering inflammation." That's tidier than the evidence. What the mechanistic work supports is that beta-glucan recognition through these receptors can modulate innate immune cell responsiveness — the phenomenon sometimes described as trained innate immunity. Whether that translates into a measurable immune benefit in a healthy cat is a separate question, and the feline literature is thin.
It is also not uniformly positive, and we'd rather say so. A controlled study of 35 cats given 1,3/1,6-beta-glucans around rabies vaccination measured antibody titers at days 0, 21, and 42. The non-supplemented group had higher post-vaccination titers than the supplemented group. Beta-glucan did not produce the expected effect in that model. A 2024 review of beta-glucan applications in dogs and cats reached a similar conclusion about the state of the field: the mechanistic rationale is strong, and species-specific clinical evidence is still being built.
So when we include 34 mg of 1,3/1,6 yeast beta-glucans in ResiliBiome, we're being clear about what that is: a formulation choice grounded in well-established mammalian immunology, included because the gut is where innate immune cells encounter dietary compounds. It is not a claim that your cat's immune response will measurably improve, and it is certainly not a claim that it prevents illness.
Most probiotics sold for cats were originally isolated from humans, dairy, or other species. The rationale for using feline-origin strains is straightforward: bacteria isolated from the cat gut have already demonstrated they can survive feline gastric acid and bile, and adhere to feline intestinal tissue. Comparative work supports this — feline-origin isolates have shown superior bile tolerance relative to well-known human-derived reference strains, with comparable adhesion. A growing body of veterinary nutrition research now argues for host-specific probiotic selection as a design principle in companion animal foods.
ResiliBiome uses three feline-origin strains: Limosilactobacillus reuteri KU-LR01, Lacticaseibacillus paracasei KU-LP01, and Pediococcus acidilactici KU-PA01. They are joined by Bifidobacterium animalis subsp. lactis and the beneficial yeast Saccharomyces boulardii.
What feline origin does not establish is clinical superiority. A strain from a cat is more likely to survive the trip and stay put. That's a real and useful advantage. It is not evidence that the strain produces better health outcomes than a well-studied strain from another source, and we won't present it that way. Probiotic effects are strain-specific — which is exactly why strain IDs on the label matter.
Secretory IgA is the antibody that coats mucosal surfaces, and it is the outcome most often reached for when someone wants to demonstrate that a probiotic "supports immunity." It's worth being precise about what has been shown in cats specifically, because this is a place where evidence from one species and one strain gets borrowed freely.
A frequently cited 2007 feline trial of Enterococcus faecium SF68 — a bacterium, not a yeast, despite how it is often described — is often summarized as showing increased fecal IgA in cats. It did not. That study reported that total fecal IgA and IgG concentrations were similar between supplemented and control cats; its significant immune finding was a difference in circulating CD4+ lymphocyte percentage. The fecal IgA increase people associate with SF68 came from a separate trial in puppies. Different species, different endpoint.
There is, however, real feline evidence. A randomized, blinded, controlled trial in healthy adult breeding cats supplemented with Saccharomyces cerevisiae var. boulardii DSM 34246 for 35 days found a significant increase in fecal IgA, alongside improvements in body condition and fecal parameters. That is a genuine feline result, in healthy cats, on an immune-relevant endpoint.
The distinction we have to draw is unmistakable: that trial used a specific, named S. boulardii strain, DSM 34246. ResiliBiome contains S. boulardii, but a different strain. Strain-level differences in probiotics are real, and evidence does not transfer between strains. We're citing that study because it's the honest state of the feline literature — not because it's a result we can claim for our own formula.
A gut-support formula shouldn't lean on a single ingredient, and the three categories in ResiliBiome do genuinely different jobs. Grouping them together as one undifferentiated blend obscures that, so here's what each part is actually for.
You'll see confident week-by-week schedules for how a cat's gut "rebuilds" on a supplement. We don't publish one, because the underlying research doesn't support that level of precision, and individual cats vary enormously depending on diet, age, prior antibiotic exposure, and baseline microbiome.
What we can say is practical: feeding trials in cats generally run four weeks or longer before measuring meaningful change, which is why our feeding guidance suggests using ResiliBiome for at least four to six weeks. For cats that are picky or sensitive, starting at half a sachet daily for three to five days makes the transition easier. If your cat has ongoing digestive signs, that's a conversation for your veterinarian — not a supplement question.
The gut really is a major immune interface in cats — that part of the story holds up. What doesn't hold up is the tidy version: a specific percentage, a guaranteed immune boost, a fixed timeline. We'd rather give you the version that survives scrutiny.
ResiliBiome is built on that principle. Feline-origin strains because they're better suited to the feline gut, not because origin proves efficacy. FOS and MOS because they do two different useful things, not because "prebiotic" sounds good. Beta-glucans because the mammalian immunology is sound, stated plainly as a formulation rationale. And a postbiotic because non-living microbial components don't have to survive the trip to matter.
Is most of a cat's immune system really in the gut?
The gut is one of the body's largest immune interfaces, and gut-associated lymphoid tissue runs the length of the digestive tract. But the widely quoted "70%" figure comes from human and general mammalian mucosal immunology, and we haven't found feline-specific research establishing that number in cats. The qualitative point is well supported; the specific percentage isn't, for cats.
How does gut health affect a cat's immune system?
Gut bacteria produce metabolites — short-chain fatty acids, modified bile acids, tryptophan derivatives — that influence inflammation and cell turnover in the intestinal lining, where a large share of immune tissue sits. In cats, this link is clearest in disease: cats with chronic enteropathy show measurably different microbial communities than healthy cats.
Can probiotics support immune health in cats?
There is genuine feline evidence on immune-relevant markers — for example, a controlled trial of a specific S. boulardii strain in healthy adult cats found a significant increase in fecal IgA over 35 days. But results are strain-specific and don't transfer between strains, and a change in a marker is not the same as a change in whether a cat gets sick. Probiotics are not a treatment or a preventive for any disease.
What are beta-glucans?
Polysaccharides from yeast and fungal cell walls. Innate immune cells recognize them through receptors including Dectin-1, which is how a dietary compound can act as an immune signal. The mechanism is well described in mammals generally. Feline-specific outcome data are limited, and at least one controlled feline study did not find the expected effect.
Does a feline-origin probiotic work better for cats?
Feline-origin strains have a real practical advantage: they've already shown they can survive feline stomach acid and bile and adhere to feline intestinal tissue. Comparative studies support that. But origin alone does not demonstrate better health outcomes — that requires strain-specific evidence, and it should be evaluated strain by strain.
What does dysbiosis mean?
An imbalance in the gut microbial community — typically reduced diversity, fewer beneficial organisms, and more of the ones associated with inflammation. In cats it can be quantified with a validated feline dysbiosis index, and roughly three-quarters of cats with chronic enteropathy show an altered profile by that measure.
Do FOS and MOS do the same thing?
No, and this is a common oversimplification. FOS is fermentable — beneficial bacteria consume it, producing short-chain fatty acids and lowering gut pH. MOS is only partially fermented; its main documented role is binding the mannose-specific fimbriae that some pathogens use to attach to the gut wall, so they pass through instead of colonizing. Both support the gut environment, by different routes.
We've covered what the feline gut microbiome is and what disrupts it, the effect of antibiotics on it, what probiotics do and don't do for diarrhea, and now the gut–immune connection. If you want to be able to read a probiotic label properly — and tell a meaningful one from a vague one — start with Cat Probiotics: Strain IDs, CFU, and What Matters.